Biolife Solutions (BLFS) Current Assets (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Current Assets data on file, last reported at $133.2 million in Q1 2026.

• Current Assets for Q1 2026 came in at $133.2 million, up 1.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $133.2 million (up 1.6% YoY), and the FY2025 annual result was $136.6 million, down 8.2% from the prior year.
• Current Assets retreated to $133.2 million in Q1 2026 per BLFS's latest filing, from $136.6 million in the prior quarter.
• Over five years, Current Assets peaked at $148.8 million in Q4 2024 and troughed at $88.2 million in Q2 2024.
• A 5-year average of $123.1 million and a median of $125.4 million in 2025 frame the typical range for Current Assets.
• The sharpest annual moves came in 2024 and 2025: Current Assets decreased 26.69% in 2024, then jumped 42.21% in 2025.
• A 5-year view of Current Assets shows it stood at $138.5 million in 2022, then decreased by 12.89% to $120.6 million in 2023, then increased by 23.35% to $148.8 million in 2024, then fell by 8.2% to $136.6 million in 2025, then dropped by 2.45% to $133.2 million in 2026.
• Business Quant data shows BLFS's Current Assets at $133.2 million in Q1 2026, $136.6 million in Q4 2025, and $126.6 million in Q3 2025.